Tenet Healthcare (THC) Gains from Sales and Divestitures (2009 - 2017)

Tenet Healthcare (THC) has 9 years of Gains from Sales and Divestitures data on file, last reported at $960836.0 in Q1 2017.

• Quarterly Gains from Sales and Divestitures fell 21.44% year-over-year to $960836.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was $960836.0 (down 21.44% YoY) and the FY2016 annual result came in at $1.6 million, up 35.9% from the prior year.
• Gains from Sales and Divestitures declined to $960836.0 in Q1 2017 per THC's latest filing, from $1.6 million in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $1.6 million in Q4 2016, with the low at $839353.0 in Q1 2014.
• Average Gains from Sales and Divestitures over 5 years is $1.1 million, with a median of $996363.0 recorded in 2015.
• Year-over-year, Gains from Sales and Divestitures plunged 76.04% in 2013 and surged 41.41% in 2016.
• Tenet Healthcare's Gains from Sales and Divestitures stood at $966838.0 in 2013, then grew by 4.46% to $1.0 million in 2014, then gained by 19.83% to $1.2 million in 2015, then surged by 35.9% to $1.6 million in 2016, then plunged by 41.58% to $960836.0 in 2017.
• Business Quant data shows THC's Gains from Sales and Divestitures at $960836.0 in Q1 2017, $1.6 million in Q4 2016, and $1.5 million in Q3 2016.